AVIR
Price
$5.26
Change
+$0.11 (+2.14%)
Updated
Sep 17 closing price
Capitalization
413.86M
48 days until earnings call
Intraday BUY SELL Signals
CELC
Price
$84.91
Change
+$2.33 (+2.82%)
Updated
Sep 17 closing price
Capitalization
4.04B
61 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AVIR vs CELC

AVIR vs CELC Comparison Chart in %
View a ticker or compare two or three
VS
AVIR vs. CELC commentary
Sep 18, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVIR is a Hold and CELC is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CELC($4.04B) has a higher market cap than AVIR($414M). AVIR YTD gains are higher at: 47.339 vs. CELC (-14.869). AVIR has higher annual earnings (EBITDA): -183.19M vs. CELC (-204.02M). CELC has more cash in the bank: 754M vs. AVIR (219M). AVIR has less debt than CELC: AVIR (424K) vs CELC (754M). AVIR (0) and CELC (0) have equivalent revenues.
AVIRCELCAVIR / CELC
Capitalization414M4.04B10%
EBITDA-183.19M-204.02M90%
Gain YTD47.339-14.869-318%
P/E RatioN/AN/A-
Revenue00-
Total Cash219M754M29%
Total Debt424K754M0%
FUNDAMENTALS RATINGS
AVIR vs CELC: Fundamental Ratings
AVIR
CELC
OUTLOOK RATING
1..100
8789
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
83
Overvalued
PROFIT vs RISK RATING
1..100
10046
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
4258
P/E GROWTH RATING
1..100
93100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AVIR's Valuation (64) in the Biotechnology industry is in the same range as CELC (83) in the Miscellaneous Commercial Services industry. This means that AVIR’s stock grew similarly to CELC’s over the last 12 months.

CELC's Profit vs Risk Rating (46) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for AVIR (100) in the Biotechnology industry. This means that CELC’s stock grew somewhat faster than AVIR’s over the last 12 months.

AVIR's SMR Rating (98) in the Biotechnology industry is in the same range as CELC (100) in the Miscellaneous Commercial Services industry. This means that AVIR’s stock grew similarly to CELC’s over the last 12 months.

AVIR's Price Growth Rating (42) in the Biotechnology industry is in the same range as CELC (58) in the Miscellaneous Commercial Services industry. This means that AVIR’s stock grew similarly to CELC’s over the last 12 months.

AVIR's P/E Growth Rating (93) in the Biotechnology industry is in the same range as CELC (100) in the Miscellaneous Commercial Services industry. This means that AVIR’s stock grew similarly to CELC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVIRCELC
RSI
ODDS (%)
Bearish Trend 1 day ago
61%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 15 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
87%
COMPARISON
Comparison
Sep 18, 2026
Stock price -- (AVIR: $5.26 vs. CELC: $84.91)
Brand notoriety: AVIR and CELC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVIR: 93% vs. CELC: 57%
Market capitalization -- AVIR: $413.86M vs. CELC: $4.04B
AVIR [@Biotechnology] is valued at $413.86M. CELC’s [@Biotechnology] market capitalization is $4.04B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.09B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVIR’s FA Score shows that 0 FA rating(s) are green while CELC’s FA Score has 0 green FA rating(s).

  • AVIR’s FA Score: 0 green, 5 red.
  • CELC’s FA Score: 0 green, 5 red.
According to our system of comparison, both AVIR and CELC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVIR’s TA Score shows that 3 TA indicator(s) are bullish while CELC’s TA Score has 4 bullish TA indicator(s).

  • AVIR’s TA Score: 3 bullish, 5 bearish.
  • CELC’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CELC is a better buy in the short-term than AVIR.

Price Growth

AVIR (@Biotechnology) experienced а +1.54% price change this week, while CELC (@Biotechnology) price change was -0.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +17.12%. For the same industry, the average monthly price growth was -4.65%, and the average quarterly price growth was +7.71%.

Reported Earning Dates

AVIR is expected to report earnings on Nov 05, 2026.

CELC is expected to report earnings on Nov 18, 2026.

Industries' Descriptions

@Biotechnology (+17.12% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
AVIR
Daily Signal:
Gain/Loss:
CELC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DSHZX13.860.14
+1.02%
Brinker Capital Destinations Shelter Z
PAMCX90.19N/A
N/A
T. Rowe Price Mid-Cap Growth Adv
VSVIX39.35N/A
N/A
Victory Integrity Small-Cap Value Y
LCBSX58.65N/A
N/A
ClearBridge Select FI
AIWEX22.95N/A
N/A
Cavanal Hill World Energy & Power Ins

AVIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVIR has been loosely correlated with AXON. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if AVIR jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVIR
1D Price
Change %
AVIR100%
+2.14%
AXON - AVIR
46%
Loosely correlated
-3.19%
KRRO - AVIR
38%
Loosely correlated
-14.68%
VCYT - AVIR
36%
Loosely correlated
+5.38%
AMRN - AVIR
35%
Loosely correlated
+0.22%
CELC - AVIR
34%
Loosely correlated
+2.82%
More

CELC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CELC has been closely correlated with IMA. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if CELC jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELC
1D Price
Change %
CELC100%
+2.82%
IMA - CELC
76%
Closely correlated
+1.83%
SLXN - CELC
50%
Loosely correlated
+11.76%
IMVT - CELC
41%
Loosely correlated
+3.49%
ANRO - CELC
39%
Loosely correlated
+3.27%
VKTX - CELC
39%
Loosely correlated
-0.54%
More